Arbor Vita Corporation and Walter Reed Army Institute of Research Sign CRADA for Traumatic Brain Injury (TBI) Collaboration
Published: Sep 08, 2008
SUNNYVALE, CA--(Marketwire - September 08, 2008) - The U.S. Department of Applied Neurobiology at Walter Reed Army Institute of Research and Arbor Vita Corporation have signed a CRADA for R&D of treatments for traumatic brain injury. The alliance is based on discoveries from a collaboration between AVC and NoNO Inc., of Toronto, and will explore the use of the companies' NA-1 compound as a novel neuroprotective agent for severe brain injury of soldiers and civilians injured in explosions such as roadside bombs. NA-1 is an investigational compound that targets a PDZ protein and is in clinical trials for the treatment of stroke.